A hypoxia efficient imidazole-based Ru(ii) arene anticancer agent resistant to deactivation by glutathione†
Abstract
A slow hydrolyzing imidazole-based RuII-arene complex [(L)RuII(η6-p-cym)(Cl)](PF6) (1) with excellent stability in the extracellular chloride concentration shows better activity under hypoxia and strong resistance to glutathione (GSH) in vitro under hypoxic conditions. 1 arrests the cell cycle in sub G1 and G2/M phases and leads to apoptosis.